Lessee, Operating Lease, Liability, to be Paid, Year Four of ABVC BIOPHARMA, INC. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
ABVC BIOPHARMA, INC. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • ABVC BIOPHARMA, INC. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Sep 2025 was $50,888.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

ABVC BIOPHARMA, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $50,888 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $52,905 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $46,699 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $47,320 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2023 $56,916 30 Sep 2023 10-Q 15 Nov 2023 2023 Q3
Q2 2023 $56,915 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.